tiprankstipranks
Trending News
More News >
BioLargo Inc (BLGO)
OTHER OTC:BLGO
US Market

BioLargo (BLGO) Income Statement

Compare
69 Followers

BioLargo Income Statement

Last quarter (Q3 2025), BioLargo's total revenue was $1.10M, a decrease of -69.84% from the same quarter last year. In Q3, BioLargo's net income was $-6.48M. See BioLargo’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 17.78M$ 12.23M$ 5.88M$ 2.53M$ 2.43M
Gross Profit
$ 7.85M$ 6.15M$ 2.86M$ 1.10M$ 1.23M
Operating Expenses
$ 12.18M$ 10.34M$ 7.98M$ 7.48M$ 8.67M
Depreciation and Amortization
$ 255.00K$ 0.00$ 45.00K$ 20.00K$ 58.00K
EBITDA
$ -4.06M$ -4.19M$ -5.10M$ -6.70M$ -7.83M
Operating Income
$ -4.33M$ -4.19M$ -5.12M$ -6.38M$ -7.45M
Other Income/Expenses
$ 1.93M$ -68.00K$ 61.00K$ -458.00K$ -2.12M
Pretax Income
$ -2.40M$ -4.63M$ -5.13M$ -6.89M$ -9.70M
Net Income
$ -2.40M$ -3.50M$ -4.50M$ -7.38M$ -10.47M
Per Share Metrics
Basic EPS
$ -0.01$ -0.01$ -0.02$ -0.03$ -0.05
Diluted EPS
$ -0.01$ -0.01$ -0.02$ -0.03$ -0.05
Weighted Average Shares Outstanding
298.12M 285.96M 268.30M 247.20M 195.99M
Weighted Average Shares Outstanding (Diluted)
298.12M 285.96M 268.30M 247.20M 195.99M
Currency in USD

BioLargo Earnings and Revenue History